Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q2 FY25 Earnings Presentation
41 slides from Apollo Hospitals Enterprise's earnings presentation
Slide 1: Apollo Hospitals Enterprise Limited Earnings Update Q2 FY25
Apollo Hospitals Enterprise Limited Earnings Update Q2 FY25
Slide 2: Disclaimer
Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation nor an
Slide 3: Content
Content Financial Performance Snapshot & Business Digital Health Segment wise Update & Pharmacy Distribution 4-9 (Apollo HealthCo) Consolidated Financials 11-12 Healthcare Services 14-23 Diagnostics & Retail Health (AHLL) 25-28 Digital Health & Pharmacy Distribution (Apollo HealthCo) 30-37 Annexure
Slide 4: Financial Performance Snapshot Q2FY25
Financial Performance Snapshot Q2FY25 Growth Growth Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) YoY(%) Margin PAT YoY(%) Healthcare Services 29,032 14% 7,220 14% 24.9% 3,643 12.5% 16% Offline PD ^ 20,144 18% 1,527 17% 7.6% Apollo HealthCo Online PD^ & 2,678 16% (1,006) Vs (1,690) in Q2F24 2
Slide 5: Financial Performance Snapshot H1FY25
Financial Performance Snapshot H1FY25 Growth Growth Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) YoY(%) Margin PAT YoY(%) Healthcare Services 55,405 14% 13,437 14% 24.3% 6,927 12.5% 20% Offline PD ^ 38,513 16% 2,915 14% 7.6% Apollo HealthCo Online PD^ & ( 2,169 ) 5,130 18% Vs (3,506) in H1FY
Slide 6: Largest Pan India Hospital Chain
Largest Pan India Hospital Chain Capacity Operational/ Hospitals Beds1 Census Beds Overall Total 73 10,138 9,423 Delhi: 5 Amritsar: 1 Noida: 1 Owned Hospitals 45 8,709 7,994 Bilaspur: 1 Kanpur: 1 Lucknow: 1 Indirapuram: 1 Managed Hospitals 6 790 790 Jaipur: 1 Day Surgery & 22 639 639 Cradle (AHLL) A
Slide 7: AHLL: Transforming Retail Health through access and convenience
AHLL: Transforming Retail Health through access and convenience Apollo Health & Lifestyle Ltd Out-of-Hospital care • Outpatient Clinics • Diagnostics • Day Surgery centers • Single Specialty Facilities :- Dialysis, Sugar and Dental Organizing the unorganized • Pathology – Organized chains represent
Slide 8: AHL India's Largest Omni-channel Healthcare Platform
AHL| India’s Largest Omni-channel Healthcare Platform Apollo HealthCo Ltd Apollo 24|7 Offline Pharmacy Distribution Unmatched Size Key Differentiators • India’s largest Organized Pharmacy Platform with • 36 Mn.+ Registered Users – 771,000 Daily Active Users • Built digital business scale in 1/3rd th
Slide 9: Clinical Updates and New Initiatives
Clinical Updates and New Initiatives • Apollo main hospital, Chennai became First center in India to complete 6,000 Da Vinci Robotic surgeries. 17,000+ robotic surgeries have been performed across all units. • Apollo cancer center, Chennai performed CAR T cell therapy for 6 year old Male patient fro
Slide 10: Consolidated Financials
Consolidated Financials Consolidated Financials © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 10
Slide 11: Consolidated Financials Q2FY25
Consolidated Financials Q2FY25 (` mio) Digital Health ` Mio Healthcare Diagnostics & & Pharmacy Consol Overall Consolidated Revenue grew by 15% to ` 55,893 mio. Services Retail Health Distribution Total Revenues 29,032 4,039 22,822 55,893 EBITDA grew by 30% to ` 8,155 mio. EBITDA (Pre 24|7 Cost) 7,2
Slide 12: Consolidated Financials H1FY25
Consolidated Financials H1FY25 (` mio) Overall Consolidated Revenue grew by 15% to ` 106,749 mio. Digital Health Healthcare Diagnostics & ` Mio & Pharmacy Consol Services Retail Health EBITDA grew by 31% to ` 14,906 mio. Distribution Total Revenues 55,405 7,700 43,643 106,749 PAT grew by 71% to ` 6,
Slide 13: Healthcare Services Hospitals
Healthcare Services Hospitals © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 13
Slide 14: Healthcare Services Financials
Healthcare Services Financials (` mio) ` Mio Q2FY25 Q2FY24 YoY H1FY25 H1FY24 YoY No of Hospitals 45 44 45 44 Healthcare Services Revenue grew by 14% in Q2FY25 Operating beds 7,994 7,765 3% 7,994 7,765 3% (Inpatient Volume grew by 8% ; Price & case mix of 6%) Occupancy 73% 68% 70% 65% IP Discharges 1
Slide 15: Inpatients Revenue Mix H1FY25
Inpatients Revenue Mix H1FY25 IPS Paed Transplts Uro PSU & Govt 3% Cardio 3% 6% Nephro 3% 19% 10% 4% Self Pay Obs&Gynac 4% Gen Surg 4% 40% 8% Inpatient Inpatient Others Specialty Mix Payor Mix 17% Onco* 9% Internal Med 10% 44% 6% Gastro 10% Neuro Insurance Ortho * Oncology includes Radiotherapy and
Slide 16: Healthcare Services: Operational Snapshot
Healthcare Services : Operational Snapshot Metros: Chennai, Hyderabad, Bangalore, Mumbai, Kolkata and Delhi H1FY25 Metros Non Metros Non Metros (includes Tier1 & Tier2 cities) Ahmedabad, Bhubaneshwar, Lucknow, Operating Indore, Guwahati, Madurai, Trichy, 4,558 3,436 Nellore,Vizag, Kakinada, Mysore,
Slide 17: Tamil Nadu Region
Tamil Nadu Region Metro:- Chennai ; Non Metro:- Madurai, Karur, Karaikudi, Trichy and Nellore Nellore Nellore Tamil Nadu Region Chennai Q2FY25 Q2FY24 YoY H1FY25 H1FY24 YoY Operating Beds 2,048 2,049 0.0% 2,048 2,049 0.0% Bed Occupancy Rate (%) 64% 62% 64% 61% Inpatient volume 39,280 37,868 3.7% 76,7
Slide 18: AP, Telangana Region
AP, Telangana Region Metro:- Hyderabad; Non Metro:- Karimnagar, Vizag and Kakinada Vishakhapatnam AP, Telangana Region Q2FY25 Q2FY24 Q2FY24 YoY H1FY25 H1FY24 YoY Operating Beds 1,240 1,270 -2.4% 1,240 1,270 -2.4% Bed Occupancy Rate (%) 74% 60% 69% 57% Inpatient volume 24,078 20,475 17.6% 43,807 39,0
Slide 19: Karnataka Region
Karnataka Region Metro:- Bangalore; Non Metro:- Mysore Karnataka Region Q2FY25 Q2FY24 YoY H1FY25 H1FY24 YoY Operating Beds 772 718 7.5% 772 718 7.5% Bed Occupancy Rate (%) 80% 73% 77% 69% Inpatient volume 18,935 16,874 12.2% 36,230 31,967 13.3% (1) Outpatient volume 72,052 55,296 30.3% 132,263 102,9
Slide 20: Eastern Region
Eastern Region Metro:- Kolkata; Non Metro:- Guwahati, Bhubaneshwar, Bilaspur and Rourkela Eastern Region Q2FY25 Q2FY24 YoY H1FY25 H1FY24 YoY Operating Beds 1,847 1,771 4.3% 1,847 1,771 4.3% Guwahati Bed Occupancy Rate (%) 80% 77% 78% 73% Inpatient volume 35,442 32,715 8.3% 68,376 62,292 9.8% Outpati
Slide 21: Western Region
Western Region Metro:- Navi Mumbai; Non Metro:- Nashik and Ahmedabad Western Region Q2FY25 Q2FY24 YoY H1FY25 H1FY24 YoY Operating Beds 870 861 1.0% 870 861 1.0% Ahmedabad Bed Occupancy Rate (%) 67% 61% 61% 54% Inpatient volume 14,543 14,025 3.7% 27,086 24,179 12.0% Outpatient volume (1) 48,796 57,44
Slide 22: Northern Region
Northern Region Metro:- Delhi; Non Metro:- Lucknow and Indore Northern Region Delhi Q2FY25 Q2FY24 YoY H1FY25 H1FY24 YoY Operating Beds 1,217 1,096 11.0% 1,217 1,096 11.0% Lucknow Bed Occupancy Rate (%) 74% 77% 73% 76% Inpatient volume 27,690 25,721 7.7% 54,532 49,645 9.8% (1) Outpatient volume 92,90
Slide 23: Healthcare Services: Expansion Plan
Healthcare Services: Expansion Plan Balance Total Census Project Cost Location Nature Project Cost Beds Beds (in Crs) (in Crs) Expected commissioning : FY26 Royal Mudhol Pune Hospital Asset Acquisition 400 325 ₹ 630 ₹ 270 Sonarpur, Kolkata Hospital Asset Acquisition 270 220 ₹ 310 ₹ 160 Gachibowli, H
Slide 24: Diagnostics & Retail Health Apollo Health & Lifestyle Ltd
Diagnostics & Retail Health Apollo Health & Lifestyle Ltd © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 24
Slide 25: Executive Summary
Executive Summary Primary Care Diagnostics Specialty Care Core revenues of Primary Care grew by 14% Wellness segment volume grew by ~37% Spectra: ~19% YoY revenue growth in YoY in Q2’FY25 YoY in Q2’FY25 & contributed ~19% to the H1’FY25 growth driven by Diagnostics revenue operationalization o
Slide 26: AHLL Financials Q2FY25
AHLL Financials Q2FY25 (` mio) Corporate / Intra Primary Care Diagnostics Specialty Care AHLL Group AHLL Revenues grew by 14% YoY in Q2’ Revenue 1,093 1,345 1,808 -208 4,039 EBITDA 203 181 209 -178 414 FY25; primarily attributed to maturing Q2FY25 margin (%) 18.5% 13.4% 11.6% 10.3% network EBIT 130
Slide 27: AHLL Financials H1FY25
AHLL Financials H1FY25 (` mio) Corporate / Intra Primary Care Diagnostics Specialty Care AHLL Group AHLL Revenues grew by 14% YoY in H1’ Revenue 2,058 2,509 3,533 -400 7,700 FY25; primarily attributed to maturing EBITDA 382 291 393 -343 723 network H1FY25 margin (%) 18.6% 11.6% 11.1% - 9.4% EBIT 239
Slide 28: Diagnostics: Key Parameters
Diagnostics : Key Parameters Gross Revenue (INR Mn) EBITDA (INR Mn)1 Operational footprint (as of Sep 30, 2024) 12% 14% 13% ~330+ 10% 9% ~330+ Cities Cities presence 1,345 168 181 presence 1,239 1,169 1,164 149 1,122 112 110 1 Q2 FY24 Q3 FY24 Q4 FY24 Q1 FY25 Q2 FY25 Q2 FY24 Q3 FY24 Q4 FY24 Q1 FY25 Q
Slide 29: Digital Health & Pharmacy Distribution Apollo HealthCo
Digital Health & Pharmacy Distribution Apollo HealthCo © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 29
Slide 30: India's Largest Omni-Channel Healthcare Platform
India’s Largest Omni-Channel Healthcare Platform Apollo 247 Digital Platform Apollo Pharmacy Platform 6,228 Stores ~16.5% Omni Private ~36 Mn+ Registrations Added - H1 202 label / generics Chandigarh: 4 mix Himachal Pradesh: 6 Closed – H1 4 - H1’ FY 25 Uttarakhand: 35 ~9,727 Doctors Punjab: 64 Net –
Slide 31: Apollo HealthCo Financials Q2FY25
Apollo HealthCo Financials Q2FY25 (` mio) Online Offline Pharmacy Total ` Mio Pharmacy Healthco (Q2’ FY25 vs Q2’ FY24); Distribution & HealthCo Distribution Apollo 247 o 17% growth in revenue in Q2’ FY25 vs Q2’ FY24 Total Revenues 20,144 2,678 22,822 EBITDA (Pre 24|7 Cost)* 1,527 346 1,874 o PAT pos
Slide 32: Apollo HealthCo Financials H1FY25
Apollo HealthCo Financials H1FY25 (` mio) Online Offline Pharmacy Total ` Mio Pharmacy Distribution & HealthCo Distribution Healthco (H1’FY25 vs H1’FY24); Apollo 247 Total Revenues 38,513 5,130 43,643 o 16% growth in revenue in H1’FY25 vs H1’FY24 EBITDA (Pre 24|7 Cost)* 2,915 680 3,595 margin (%) 7.
Slide 33: Apollo HealthCo: Advent Investment - Tranche 1 of INR 1732 crs completed
Apollo HealthCo : Advent Investment - Tranche 1 of INR 1732 crs completed • Apollo Healthco Limited (“AHL”) to raise equity capital of INR 2,475 Crs (USD 300 Mn) from Advent International (“Advent”)1, one of the largest global private equity investors with an AUM of over USD 94 Bn. Tranche 1 of INR
Slide 34: Synergetic Benefit of the Keimed Merger
Synergetic Benefit of the Keimed Merger Becoming India’s Leading Healthcare Provider 1 Leading Pharma End-to-end, Patient retention Distributor seamless, omnichannel User satisfaction + business model of pharmacy Cross selling Growing Omni distribution with a Apollo Channel Platform fast-growing dig
Slide 35: Proposed Transaction Structure and Steps (1/2)
Proposed Transaction Structure and Steps (1/2) Post Advent Tranche 1 Investment Post Advent Tranche 2 Investment Pre-Transaction (T) (T+12 Months) AHEL ESOP AHEL Advent ESOP AHEL Advent ESOP 95% 5*% 83.1% 12.5%1 4.4% 79.0% 16.9% 4.1% 2% 11.2% AHL AHL Keimed AHL Keimed Tranche 1 Tranche 2 • Advent in
Slide 36: Proposed Transaction Structure and Steps (2/2)
Proposed Transaction Structure and Steps (2/2) Launch of Merger Process Post Merger (T+15 Months) (T+30 Months) Keimed AHEL Promoters Keimed 61.5% AHEL 79.0% Shareholders Other minority Advent ESOP FHPL partners 59.2%** 25.7%# Min Max 16.9% 4.1% 16.1% 11.2% Advent ESOP 11.2%* 12.1%+ 3.0% AHL Keimed
Slide 37: Proforma Combined Financials Snapshot H1FY25
Proforma Combined Financials| Snapshot H1FY25 (` mio) FY24 Offline Pharma Online Pharma Combined Combined Distribution Total Healthco Keimed Combined Distribution+247 H1’FY25 Q2’FY25 Revenue 137,701 38,513 5,130 43,643 63,120 78,964 41,585 EBITDA,Pre 9,614 2,804 656 3,461 1,966 5,427 2,847 INDAS EBI
Slide 38: Annexure
Annexure © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 38
Slide 39: Basis of Consolidation
Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services Platform 100.00% Tondiarpet - Chennai Chennai A
Slide 40: IND AS 116: Impact on P&L and Balance Sheet H1FY25
IND AS - 116 : Impact on P&L and Balance Sheet –H1FY25 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use Asset 12,969 Revenue Right of use Asset 23,978 Revenue as of Other expenses 513 as of Other expenses 1,218
Slide 41: Thank you !!
Thank you !! 41
Apollo Hospitals Enterprise — Q2 FY25 Earnings Presentation on 6ix